Association between iris constitution and apolipoprotein E gene polymorphism in hypertensives

Journal of Alternative and Complementary Medicine

Volumn 10, Issue 6, 2004, Pages 1101-1105

  Um, Jae Young ^a,b   Hwang, Chung Yeon ^b   Hwang, Woo Jun ^b   Kang, Sung Do ^b   Do, Keum Rok ^b   Cho, Ju Jang ^b   Cho, Jae Woon ^b   Kim, Sung Hoon ^a   Shin, Tae Yong ^c   Kim, Yun Kyung ^b   Kim, Hyung Min ^a   Hong, Seung Heon ^b  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALTERNATIVE MEDICINE; ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; EYE COLOR; FEMALE; GASTROINTESTINAL DISEASE; GENETIC RISK; HEART DISEASE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IRIDOLOGY; IRIS; IRIS DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGICAL ADAPTATION; OPHTHALMOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMPLEMENTARY THERAPIES; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; HUMANS; HYPERTENSION; IRIS; KOREA; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 19944430449     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2004.10.1101     Document Type: Article

References (15)

1. Brega A, Scacchi R, Cuccia M, Kirdar B, Peloso G, Corbo RM. Study of 15 protein polymorphisms in a sample of the Turkish population. Hum Biol 1998;70:715-728.
2. Ernst E. Iridology: not useful and potentially harmful. Arch Ophthalmol 2000;118:120-121.
3. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21.
4. Hixon JE. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Apolipoprotein E polymorphism affects atherosclerosis in young males. Arterioscler Thromb 1991;11:1237-1244.
5. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 1990;31:545-548.
6. Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H. Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke 2000;31,6:1299-1306.
7. Kumar T, Liestol K, Maehlen J, Hiorth A, Jettestuen E, Lind H, Brorson SH. Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol 2002;74,1:137-142.
8. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995;15:1280-1286.
9. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999;53:1308-1311.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
11. Odawara M, Sasaki K, Yamashita K. Beta 3-adrenergic receptor gene variant and Japanese NIDDM: a pitfall in meta-analysis. Lancet 1996;348:896-897.
12. Sharan F. Iridology: A Complete Guide to Diagnosing Through the Iris and to Related Forms of Treatment. Wellingborough, England: Thorsons Publications Ltd., 1989.
13. Shore VG, Smith ME, Perret V, Laskaris MA. Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis. J Lipid Res 1987;28:119-129.
14. Siest G, Pillot T, Regis-Bailly A, Leininger-Muller B, Steinmetz J, Galteau MM, Visvikis S. Apolipoprotein E: an important gene and protein to follow in laboratory medicine. Clin Chem 1995;41:1068-1086.
15. Wu JH, Lo SK, Wen MS, Kao JT. Characterization of apolipoprotein E genetic variations in Taiwanese: association with coronary heart disease and plasma lipid levels. Hum Biol 2002;74,1:25-31.